Aurobindo Pharma shares fall after USFDA VAI tag for API unit
Aurobindo Pharma's shares dropped nearly 2% on Wednesday, 11 November, ending a 12-day winning streak after the USFDA issued a 'Voluntary Action Indicated' (VAI) classification for an API facility of its wholly…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.